Erasca stock price
에라스카NASDAQ:ERAS · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →Erasca last closed at $14.74 (+1.10%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -16.0×. Its overall grade ranks 244 of 739 stocks in Healthcare.
About this company
Erasca last closed at $14.74 (+1.10%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 244/739
Valuation grade A+
Related stocks
- RocheCompetitor
ERK-3730 등 관련 표적 분야에서 항암 신약 개발 경쟁사가 될 수 있음
- MerckCompetitor
종양학 분야 대형 제약사로 ERASCA의 항암 파이프라인과 경쟁 관계
- Bristol Myers SquibbCompetitor
면역항암·표적항암 분야에서 Erasca와 같은 개발 영역을 다룸
ETFs holding this stock
Invesco DWA Healthcare Momentum ETF · Invesco DWA SmallCap Momentum ETF
Details →About Erasca
- What technical signals does Erasca (ERAS) have?
- Erasca current technical signals: MACD bullish cross.
- Is Erasca a cup-and-handle pattern?
- No. Erasca has no valid Cup signal right now.
- What published figures are available for Erasca?
- Market cap: $4.18B. Trailing 12 months PER: -16.0×. Latest quarter PBR: 12.68×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Erasca, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.